Search
for
Sort by
Research 331–360 of 1000+
- Repurposing Metformin for Dermatological Use: Mechanisms, Evidence, and Clinical Perspectives
- Primary cicatricial alopecia: diagnosis and treatment
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- Pathophysiology of Androgenetic Alopecia and Implications for Treatment: An Overview of Current Literature
- Natural bioactive compounds as potential sources for alleviation and treatment of androgenetic alopecia: A research advance
- Smart stimuli-responsive microneedle platforms for precision androgenetic alopecia therapy: Materials strategy and therapeutic perspectives
- Cellular Senescence and Aging in Myotonic Dystrophy
- Management of Toxicities of Targeted Therapies
- Rosemary bioactive phytochemicals as a strategy for the management of age related conditions
- A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia
- Therapeutic Intervention in Lichen Planus Pilar (LPP): Synergy of Low-Level Laser Therapy and Topical Corticosteroid
- Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
- Androgenetic Alopecia: A Review
- CONTRACEPTION AND THE SKIN
- Recent approaches of antibody therapeutics in androgenetic alopecia
- Inhibition of Inflammatory Gene Expression in Keratinocytes Using a Composition Containing Carnitine, Thioctic Acid and Saw Palmetto Extract
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Non-Steroidal Modulation of the 5-Alpha Reductase Axis: A Dual Therapeutic Strategy for Prostatic Chemoprevention and Androgenetic Alopecia
- Control of hair growth and follicle size by VEGF-mediated angiogenesis
- Dermatological drugs, topical agents, and cosmetics
- NANOCARRIER-BASED APPROACHES FOR ENHANCED MANAGEMENT OF ANDROGENETIC ALOPECIA: ADVANCEMENTS AND FUTURE PROSPECTS
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Steroid Hormones
- Updates in Treatment for Androgenetic Alopecia
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Clinical study of fibrosing alopecia in a pattern distribution in a Latin American population
- Correlation Between Nongenomic Action of C19-Steroids and COVID-19 Severity
- The genetically programmed hair growth cycle and alopecia: what is there to know?